ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT

• Main Authors: A. N. Fetisova (Author), E. I. Alexeeva (Author), T. M. Bzarova (Author), S. I. Valieva (Author), V. V. Chernikov (Author), I. V. Vinyarskaya (Author), R. V. Denisova (Author), K. B. Isaeva (Author), E. G. Chistyakova (Author), Т. V. Sleptsova (Author), N. I. Taibulatov (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2014-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: To assess the influence of the genetically engineered biologic drug etanercept on the quality of life of patients with juvenile idiopathic arthritis (JIA). Patients and methods: The research included 85 children with poly-and oligoarticular variant of the JIA at the age of 5 (2; 17) years. The...